The material on these web pages is copyrighted by Indaptus Therapeutics, Inc. (hereinafter “Indaptus”).
Permission is given to view the material on the Indaptus web pages and save that material only for personal non-commercial reference. Copying, modifying, using or distributing the material in any way is prohibited unless you obtain the permission of Indaptus. Indaptus is not able to inspect or confirm that the materials contained on the web pages that are linked to this web page are correct in every case.
Indaptus provides the information on these web pages as is and without any warranties, including merchantability and fitness for a particular purpose. In no event will Indaptus be liable for any loss of profit, business, use, or data or for indirect, special, incidental or consequential damages of any kind, whether based in contract, negligence or other tort. Indaptus may make changes to the web page materials at any time without notice and without obligation to update the materials contained on these web pages.
We do not seek or collect any personally identifiable data from users and visitors of our website, rather we receive and store only information voluntarily, intentionally, and willfully submitted to us by those users and visitors. Such information may be submitted for the purpose of sending us inquiries, comments, or feedback. The information may include contact information (i.e. e-mail address) and demographic information (i.e. age, zip code). The information submitted is then received and stored by us and is only used for the purposes for which it is submitted.
Any individual who has submitted information to our website has the option of changing, modifying or removing information previously provided by him/her by sending us an e-mail specifying the requested modification or removal of certain information submitted.
For any further information or questions please contact: email@example.com.
The Indaptus Therapeutics website contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act. These include statements regarding management’s expectations, beliefs and intentions regarding, among other things, our product development efforts, business, ﬁnancial condition, results of operations, strategies, plans and prospects. Forward-looking statements can be identiﬁed by the use of forward-looking words such as “believe,” “expect,” “intend,” “plan,” “may,“ “should,“ “could,“ “might,“ “seek,“ “target,“ “will,” “project,“ “forecast, “continue,” or “anticipate,” or their negatives or variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical matters. For example, forward-looking statements are used on this website when we discuss Indaptus’ future plans and expected timeline of our development pipeline.
Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking statements. These risks are identified and discussed under the heading “Risk Factors” in our periodic filings with the SEC.
The website contains information about investigation-stage drug products under development that have not yet been approved by the U.S. Food and Drug Administration for commercial distribution in the United States. All representations on this website are based upon investigations in certain clinical and other research, but which accordingly should not be construed as general claims for the safety or efficacy of the products when used by patients.